Mishiba Co., Ltd. announced that the company will hold a board meeting on December 25, 2025 to review and pass the debt restructuring bill. The company plans to pay a claim of 5.252,900 yuan against Shengmin Medical Management Co., Ltd. to cover the amount due to Foshan Zhengdali Branch of 5.3049 million yuan. This debt restructuring does not constitute a related transaction or major asset restructuring. It is within the authority of the board of directors and does not require review by the shareholders' meeting. The company has accumulated 9.45 million yuan in debt restructuring within the first 12 months. This debt restructuring is conducive to revitalizing assets, optimizing debt structure, and improving cash flow.

Mishiba Co., Ltd. announced that the company will hold a board meeting on December 25, 2025 to review and pass the debt restructuring bill. The company plans to pay a claim of 5.252,900 yuan against Shengmin Medical Management Co., Ltd. to cover the amount due to Foshan Zhengdali Branch of 5.3049 million yuan. This debt restructuring does not constitute a related transaction or major asset restructuring. It is within the authority of the board of directors and does not require review by the shareholders' meeting. The company has accumulated 9.45 million yuan in debt restructuring within the first 12 months. This debt restructuring is conducive to revitalizing assets, optimizing debt structure, and improving cash flow.